Latest filing published 15 Oct 2025 for Spruce Biosciences, INC., €3,829.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Parkman Healthcare Partners LLC: trading record in brief
Parkman Healthcare Partners LLC appears in our data through filings on Spruce Biosciences, Inc. shares, published by SEC (Form 4). We count 6 filings, every one of them for a trade on 6 October 2025.
Market trades split into 2 purchases (€7,831) and 4 sales (€8,404). Sales outweigh purchases by €573. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 15 October 2025 with an open-market sale (€3,829) in Spruce Biosciences, Inc. The last purchase on record was published on 15 October 2025, which is 390 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Parkman Healthcare Partners LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 232 shares@ US$19.326431.1% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-006126:1
- 25 shares@ US$17.45573.0% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-006126:2
- 232 shares@ US$19.3331.1% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-006012:1
- 25 shares@ US$17.463.0% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-006012:2
- 256 shares@ US$17.91080.0027% mcap100.0% of flowCommon Stock, $0.001 par value per shareSEC:0000919574-25-006012:0Canonical exit: 4 Jan 2026 (T+90)
5 of 5 declarations
